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INTRODUCTION
Rota virus is the most important etiological agent of
acquired diarrhea in infants and young children and is a
vaccine preventable disease, is considered to be most
common pathogen responsible for causing severe
diarrhea and dehydration in children less than 5 years of
age. According to WHO estimates in 2004 over five
million children aged < 5 years died from Rota virus
infection. About half of these deaths occurred in India,
Nigeria, the Democratic Republic of the Congo, Ethiopia,
China and Pakistan.1 Recent estimates show that
about 65,000 children die each year in the Eastern
Mediterranean Region (EMR) which also includes
Pakistan. Although the mortality is higher in the low-
income countries of the region, the burden of severe
Rota virus disease among less than 5 years old children
requiring hospitalization and clinical visits is equally
shared by all the countries of the region.2
Rota virus infection results in a large number of
hospitalizations, costs and mortalities.3,4 The global and
national estimates from WHO state that the proportions
of hospitalizations due to Rota virus diarrhea ranged
from 16% to 66% with a median proportion of 38% (inter-
quartile range, 26% – 43%).5 Pakistan has a population
of more than 17 million, of which 43% are children. WHO
estimates show that the mortality due to Rota virus in
children less than 5 years is 95/100,000 in under five
populations.1
In 1998, the US Food and Drug Administration approved
a live virus vaccine (Rota Shield) for use in children but
it was linked to an increased risk for intussusception.
Because the immune response to the infection reduces
the occurrence and severity of subsequent infections,
diarrhea due to Rota virus may be controlled through
vaccination.6 Rota virus illness typically begins with the
sudden onset of diarrhea and vomiting. The diarrhea is
usually watery and rarely has blood in it. Fever may be
present in most of the patients. 
The purpose of this study was to determine the
frequency of Rota virus in children hospitalized with
diarrhea lasting for less than 7 days.
METHODOLOGY
It was a cross-sectional, observational study conducted
at Diarrhea Treatment Unit, National Institute of Child
Health, Karachi, from January to June 2007. Three
hundred patients of either sex from 1 month to 5 years
with symptoms of acute gastroenteritis of less than 7
days were included in the study. Children with bloody
diarrhea and those who acquired gastroenteritis during
hospitalization for treatment of other disease were
excluded. Written consent was taken from parents/
caregiver after explaining the purpose of study. No
charges were demanded from the caregiver for the
overall treatment. As it was not an interventional study
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approval from ethical committee of the institute was not
sought.
Stool samples were collected as soon as possible within
24 – 48 hours to avoid nosocomial infection. Stool
containers were labeled with the unique patient
identifier. One spoon full of diarrhea stool recently
voided in diaper was transferred into the labeled
container with the spoon provided in container. Stool
specimens with the request and feedback form were
sent to hospital laboratory. Short-term storage was done
at 2 – 80°C in the laboratory for detection of Rota virus
by EIA (enzyme linked immunoassay) within 20 minutes
of collection. Reagent used was DAKO IDEIA present in
Rota virus EIA detection kit that contains a positive
control and a negative control which were performed
with each assay to ensure that kit reagents were used;
the positive control was deep blue and easily
distinguished from the negative control. The negative
control was colourless or faint blue.
For the purpose of the study, diarrhea was defined as
the acute occurrence (symptoms of onset less than
7 days) of at least 3 looser than normal or watery stools
in a 24 hours period; vomiting was defined as two or
more episodes of vomiting un-explained by other
reasons. Dehydration was categorized into no
dehydration (not enough signs to classify as some or
severe dehydration), some dehydration (two or more of
the following signs: (a) restless, irritable, (b) sunken
eyes, (c) drinks eagerly, thirsty and (d) skin pinch goes
back slowly) and severe dehydration (two or more of the
following signs: a. lethargic or unconscious, (b) sunken
eyes, (c) not able to drink or drink poorly and (d) skin
pinch goes back very slowly).
Data was entered and analyzed in Statistical Package
for Social Sciences (SPSS) version 10. Frequencies and
percentages were calculated for all qualitative/
categorical variables including gender, age groups,
symptoms, number of vomiting, duration of symptoms
and result of Rota virus detection (positive or negative).
Mean and standard deviation was computed for age.
Chi-square test was used to see the association of age
groups and gender with Rota virus (positive or negative),
at 5% level of significance.
RESULTS
A total of 300 children admitted with complaint of acute
watery diarrhea were evaluated. Out of 300 children,
180 (60%) were males and 120 (40%) females (M: F
ratio = 1.5: 1). The mean age of children was 20.56
(SD ± 15.14) months and age range was 1 - 60 months.
The highest frequency of symptoms was observed in 74
(24.6%) children who were between 7 - 12 months of
age, 51 (17%) children were between 1 - 6 months. A
total of 177 (59%) children had symptoms for 1 - 3 days,
and 123 (41%) children had symptoms from 4 - 6 days.
Fever was seen in 182 (60.7%) children and vomiting in
118 (39.3%). Out of 118 children who presented with
vomiting, 70 (59.3%) had 5 - 7 episodes of vomiting, 37
(31.3%) children had 2 - 4 episodes while 11 (9.3%)
children had 8 - 9 episodes of vomiting. A total of 195
(65%) children had diarrhea for 1 - 3 days and 104
(34.7%) children had diarrhea for 4 - 6 days and only
one child continued to have diarrhea for 7 - 9 days.
About 8 - 11 episodes of diarrhea per day were seen in
181 (60.3%) children, 12 - 15 episodes per day in 68
(22.7%) children and 4 - 7 episodes per day in 51 (17%)
children.
Rota virus was positive in 188 (63%) children that was
significantly high proportion as compared with 112 (37%)
children who were found to be negative for Rota virus
(p < 0.001). The highest frequency of Rota virus positive
cases (34, 18.08%) was observed in children between
7 - 12 months of age. The frequency of Rota virus
disease in children of other age groups was found to be
15.4% (n=29) between ages of 1 - 6 months, 10.1%
(n=19) cases each between ages of 13 - 18 months and
19 - 24 months, 15.9% (n=30%) cases between ages of
25 -30 months and 10.6% (n=20) cases between ages of
31 - 36 months. A total of 151 (80.31%) children with
Rota virus were under 3 years of age. A significant
association was seen between age and Rota virus
(p < 0.001). Rota virus was detected more frequently in
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Table I: Distribution of Rota virus according to age groups (n=300).
Age group Rota virus Number of
(in months) Negative Positive patients
01-06 months 22 29 51
07-12 months 40 34 74
13-18 months 23 19 42
19-24 months 13 19 32
25-30 months 7 30 37
31-36 months 3 20 23
37-42 months 1 7 8
43-48 months 3 16 19
49-54 months 0 4 4
55-60 months 0 10 10
Total 112 188 300
Figure 1: Age distribution (n = 300). Mean ± SD = 20.56 ± 15.14 months,
range = 1 - 60 months.
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males 116 (61.7%) than in females 72 (38.3%) although
association between gender and Rota virus was not
significant (p = 0.436).
Significant association was found between clinical
features of diarrhea and Rota virus (p < 0.001). Rota
virus was detected more frequently in children
presenting with fever ( n = 105) 57.7% out of 182 febrile
cases.
DISCUSSION
Rota viruses are the main pathogens responsible for
diarrheal disease worldwide especially in developing
countries. They result in a large number of
hospitalizations, costs and mortalities. Each year, Rota
viruses cause approximately 111 million episodes of
gastroenteritis in children, which result in 25 million visits
to clinic, 2 million hospitalizations and 3,52,000 to
5,92,000 deaths. Virtually, all children become infected
with Rota virus in the first 3 - 5 years of life, but severe
diarrhea and dehydration occur primarily among children
aged 3-35 months. On a worldwide basis, nearly every
child experiences Rota virus gastroenteritis by 5 years
of age.7
A study conducted in Karachi showed Rota virus
incidence to be 12.3% in 1990 and 24.4% in 1991.8
Children between the age group of 6 - 24 months were
more commonly affected by Rota virus infection. A study
in Washington DC found that most children have
developed Rota virus antibodies by age of 2 years,
which helps to explain the observed decreased
incidence in later childhood.9
Rota virus has an incubation period of 2 - 3 days. Illness
typically begins with the sudden onset of diarrhea and
vomiting. Fluid loss from diarrhea and vomiting are
sometimes severe enough to cause dehydration. Fever
is present in most patients. There is no significant
difference in clinical presentations of patients with Rota
virus and without Rota virus diarrhea.
Dual or mixed infection with human Rota virus and other
enteropathogens, namely E-coli, Giardia lamblia and
Entamoeba histolytica were found in 15% of children in
a study done in South Africa.10 Such mixed infections
tend to prolong the duration of diarrhea.11 Since bacterio-
logical studies were not performed, the bacterial etiology
of diarrheal episodes cannot be commented upon.
No test was performed for the identification of specific
Rota virus serotypes, but group-A Rota viruses are the
single most important cause of severe acute diarrhea in
young children throughout the world.12 It is a cause of
significant morbidity and mortality among children
younger than 5 years of age in India. Of the
approximately 600,000 deaths annually due to Rota
virus worldwide, more than 1, 50,000 occur in India.13,14
About 20 – 30% cases of diarrhea are due to Rota
viruses,15,16 making the development and testing of an
effective Rota virus vaccine a necessity. World Health
Organization recommends that national immunization
programs of all countries should include Rota virus
vaccine. Results from developed countries where this
has been done have shown significant reductions in the
burden of severe childhood diarrhea. Clinical trials in the
developing world are needed to look at the benefits of
Rota virus vaccination in developing countries where
vaccines are likely to have their greatest impact.17
An important limitation of this study is that it was done on
in-patient children presenting with diarrhea. In order to
have current estimates on Rota virus both community
and hospital based studies are required. Thus, the need
for a national level registry for Rota virus need to be
maintained and the Rota virus vaccine should be added
to the national immunization programme as a primary
prevention against this preventable form of diarrheal
disease.
CONCLUSION
The study has shown that Rota virus is a common cause
of diarrhea in children younger than 5 years of age. Rota
virus was found in 63% (188/300) of diarrheal cases.
About 80% of the Rota virus infection was found in
children less than 3 years of age, whereas it was 18% in
the infant age group.
Disclosure: It is a dissertation based article.
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